STAT+: Pharmalittle: More U.S. states and cities are suing insulin makers; Biden looks to boost U.S. drug manufacturing amid shortages

A growing number of state and local governments across the U.S. are suing insulin makers and PBMs over claims they conspired to illegally drive up prices.
Click here to view original post